Skip to content

Efficacy of Cap-Assisted Endoscopy for Examination of Major Duodenal Papilla and Probability of Biopsy

Efficacy of Cap-Assisted Endoscopy for Examination of Major Duodenal Papilla and Probability of Biopsy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053010
Enrollment
Unknown
Registered
2021-11-08
Start date
2021-11-04
Completion date
Unknown
Last updated
2022-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Group B2:All procedures were performed by cap-assisited endoscopy firstly and standard endoscopy later.
Group A1:All procedures were performed by standard endoscopy firstly and cap-assisited endoscopy later.
Group B1:All procedures were performed by cap-assisited endoscopy firstly and standard endoscopy later.
Group A2:All procedures were performed by standard endoscopy firstly and cap-assisited endoscopy later.

Sponsors

The Third Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years, gender is not limited; 2. Patients who plan to undergo gastroscopy.

Exclusion criteria

Exclusion criteria: 1. Those who are unable or unwilling to sign the informed consent form; 2. After upper gastrointestinal reconstruction surgery; 3. Known or suspected upper gastrointestinal stenosis or perforation; 4. Known or suspected active upper gastrointestinal bleeding; 5. Those who plan to undergo gastroscopic treatment; 6. Pregnant women and lactating women; 7. American Society of Anesthesiologists (ASA) classification >= grade 3, or contraindications to propofol use.

Design outcomes

Primary

MeasureTime frame
major duodenal papilla examination score;major duodenal papilla biopsy score;

Countries

China

Contacts

Public ContactWei Xiuqing

The Third Affiliated Hospital of Sun Yat-Sen University

13556007376@163.com+86 13556007376

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026